改善传输和促进产品市场投入之寡核苷酸治疗药物相关专家见解、最新数据、技术
制药业界专家发表加速产品开发的革新策略
本学会焦点与最新主题及范例分析:
- mRNA疗法
- CRISPR-Cas9与基因体编辑的应用
- 治疗用寡核苷酸的CMC开发之风险基础方法
- 扩编至更大疾病族群的机会
- 反股寡核苷酸的立体化学控制增强了标的疗效
- 寡核苷酸的作用机制与活体内分布的定量
- 替代性制造技术降低寡核苷酸产品制造成本：酵素生产的应用
- 晚期药物产品开发以及药物产品制造
- 寡核苷酸开发的非临床个案研究
- 法规主管机关期许
掌握您所需的研究成果、技术、人脉加速肽制剂产品投入市场
Present a Scientific Poster
Share your company's new research by presenting a poster at TIDES 2018. All posters are displayed in the exhibit & poster hall area throughout the event.
Please note that all poster presenters must be registered attendees. The deadline for poster submissions is Friday, 12 October 2018.
感谢EuroTIDES 2018科学咨询委员会的协助。
邀请全球寡核苷酸及肽领域主要研究人员担任演讲嘉宾并获其大力支持。
- Muthiah (Mano) Manoharan, Senior VP, Drug Discovery, Alnylam Pharmaceuticals, Inc, USA
- Yogesh Sanghvi, President, Rasayan, USA
- Troels Koch, VP & Head of Research, RNA Therapeutics, Roche Innovation Center Copenhagen A/S, Denmark
- Thomas Rupp, Owner, Thomas Rupp Consulting, Germany
- Professor Cy Stein, Department of Medical Oncology and Experimental Therapeutics, City of Hope Medical Center, USA
- Mike Gait, MRC Programme Leader, MRC Laboratory of Molecular Biology, UK
- Dmitry Samarsky, Oligonucleotide (RNAi) Technology and Therapeutics, Experienced Executive and Industry Expert
EuroTides is an excellent business platform to meet existing and new customers in peptides and oligonucleotides development & manufacturing and at the same time learn about today's problems and tomorrow needs.
Jurgen Machielse
Business Development Director
Zeochem
Was an excellent meeting giving me the chance to hear about new developments and to interact with colleagues in a relaxed atmosphere
Anonymous
Well attended event with attendees from all parts of peptide clinical development. The talks on peptide manufacture and issues that can arise were excellent.
Anonymous
